41 Venous Thrombectomy

Devi P. Patra, Evelyn L. Turcotte, Muriel T. Zaatar, Bernard R. Bendok, and Chandan Krishna

Abstract

Cerebral venous sinus thrombosis (CVST) is a rare cause of stroke comprising only 0.5% of all strokes. The diagnosis is often challenging due to nonspecific symptoms including headache and seizure with subtle findings in initial computed tomography (CT) scans. Significant cerebral edemas in a nonarterial territory without obvious mass lesion and flame-shaped hemorrhages are initial findings that should raise suspicion of CVST. Early diagnosis and treatment are the key to prevent fatal complications due to malignant cerebral edema and herniation. Initiation of systemic anticoagulation is the first line of management to allow recanalization of the sinus and prevent clot progression. Endovascular therapy is reserved for nonimprovement of clinical symptoms or deterioration despite therapeutic anticoagulation. Catheter-based thrombolysis is the traditional method of treatment using urokinase or alteplase, which provides higher partial recanalization rates and better neurological outcome as compared to systemic anticoagulation alone. Other methods include mechanical thrombectomy using aspiration devices, rheolytic thrombectomy, stent retriever, balloon angioplasty, and aspiration. The overall radiological success rate (complete to partial recanalization) and clinical success rate (modified Rankin Score [mRS] of 0–2) described in the literature range from 70 to 95% and 75 to 85%, respectively, with acceptable complication rates of 3 to 5% (new or worsening hemorrhage).

Schlüsselwörter

venous sinus thrombosis - venous thrombectomy - venous thrombolysis - mechanical thrombectomy - cortical venous thrombosis

• 1 Bushnell C, Saposnik G. Evaluation and management of cerebral venous thrombosis.. Continuum (Minneap Minn) 2014; 20 (Suppl. 2 Cerebrovascular Disease) 335-351 PubMed

• 2 Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, . Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).. Stroke 2004; 35 (3) 664-670 PubMed

• 3 deVeber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis in children.. N Engl J Med 2001; 345 (6) 417-423 PubMed

• 4 Einhäupl KM, Villringer A, Meister W et al. Heparin treatment in sinus venous thrombosis.. Lancet 1991; 338 (8767) 597-600 PubMed

• 5 de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis.. Stroke 1999; 30 (3) 484-488 PubMed

• 6 Stam J, De Bruijn SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis.. Cochrane Database Syst Rev 2002; (4) CD002005 PubMed

• 7 Coutinho JM, Ferro JM, Canhão P, Barinagarrementeria F, Bousser MG, Stam J, . Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis.. Stroke 2010; 41 (11) 2575-2580 PubMed

• 8 Saposnik G, Barinagarrementeria F, Brown Jr RD, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association.. Stroke 2011; 42 (4) 1158-1192 PubMed

• 9 Einhäupl K, Stam J, Bousser MG, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients.. Eur J Neurol 2010; 17 (10) 1229-1235 PubMed

• 10 Aoun SG, Rahme RJ, Batjer HH, Bendok BR. New guidelines for the management of cerebral venous thrombosis.. Neurosurgery 2011; 69 (2) N15-N17 PubMed

• 11 Viegas LD, Stolz E, Canhão P, Ferro JM. Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review.. Cerebrovasc Dis 2014; 37 (1) 43-50 PubMed

• 12 Canhão P, Falcão F, Ferro JM. Thrombolytics for cerebral sinus thrombosis: a systematic review.. Cerebrovasc Dis 2003; 15 (3) 159-166 PubMed

• 13 Wasay M, Bakshi R, Kojan S, Bobustuc G, Dubey N, Unwin DH. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis.. Stroke 2001; 32 (10) 2310-2317 PubMed

• 14 Dentali F, Squizzato A, Gianni M et al. Safety of thrombolysis in cerebral venous thrombosis. A systematic review of the literature.. Thromb Haemost 2010; 104 (5) 1055-1062 PubMed

• 15 Dashti SR, Hu YC, Yao T et al. Mechanical thrombectomy as first-line treatment for venous sinus thrombosis: technical considerations and preliminary results using the AngioJet device.. J Neurointerv Surg 2013; 5 (1) 49-53 PubMed

• 16 Choulakian A, Alexander MJ. Mechanical thrombectomy with the penumbra system for treatment of venous sinus thrombosis.. J Neurointerv Surg 2010; 2 (2) 153-156 PubMed

• 17 Bagley LJ, Hurst RW, Galetta S, Teener J, Sinson GP. Use of a microsnare to aid direct thrombolytic therapy of dural sinus thrombosis.. AJR Am J Roentgenol 1998; 170 (3) 784-786 PubMed

• 18 Philips MF, Bagley LJ, Sinson GP et al. Endovascular thrombolysis for symptomatic cerebral venous thrombosis.. J Neurosurg 1999; 90 (1) 65-71 PubMed

• 19 Ilyas A, Chen CJ, Raper DM et al. Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a systematic review.. J Neurointerv Surg 2017; 9 (11) 1086-1092 PubMed

• 20 Siddiqui FM, Dandapat S, Banerjee C et al. Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases.. Stroke 2015; 46 (5) 1263-1268 PubMed

• 21 Coutinho JM, Ferro JM, Zuurbier SM et al. Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial.. Int J Stroke 2013; 8 (2) 135-140 PubMed